Skip to main content

Sun Valley ID & Austin TX— CancerConnect launches community for individuals with neuroendocrine tumors (NET). This community will provide patients and their loved ones with information and support. Join the conversation in the NET community here.

Although neuroendocrine tumors have historically been considered rare, the incidence of neuroendocrine tumors has been increasing. Recent statistics suggest that the current number of people with neuroendocrine tumors exceeds 100,000 in the United States—more than the number of people with other, better known cancers like pancreatic or stomach cancer. The increase in NET diagnoses parallels improved diagnosis and treatments around the world.

CancerConnect founder Charles Weaver, MD says, “Our decision to launch this community reflects our commitment to providing people who have been diagnosed with rare or less common syndromes a place to connect. Everyone facing a serious diagnosis should have access to a trusted resource to learn more about their condition and find support from others facing a similar diagnosis.”

Join The NET Community of Patients & Caregivers

Scroll to Continue

Recommended Articles

Image placeholder title

Relatlimab Anti-LAG-3 Antibody

Is combination immunotherapy with the anti-LAG-3 antibody relatlimab and Opdivo the next advance in melanoma treatment?

Image placeholder title

Blood Cancers and COVID-19 - What You Need to Know

COCID-19 puts individuals with leukemia, lymphoma, myeloma and MPN's at risk - learn how to optimize your care.

Research increasingly shows that patients seek validation, information, and support via social media. Unlike other social media platforms, CancerConnect allows individuals to interact in a confidential, safe, and secure environment with others affected with their condition. Individuals access these communities directly at or from partner communities like The Ohio State James Cancer Institute, Roswell Park, and connecting patients to a variety of individuals and experiences across the U.S.

CancerConnect now has more than 60 specific groups of individuals seeking support and information from others with cancer, blood conditions, and hereditary risk as well as groups focused on caregiving, health and wellness, clinical trials, insurance, nutrition and survivorship. CancerConnect provides support for anyone affected by a diagnosis of cancer. Together, these communities offer an online destination populated with rich content to support the many ongoing needs of individuals battling cancer.

About Cancer Connect

Originally established in 1996 as a cancer patient education resource, Cancer Connect has consistently expanded its platform by integrating technologic advances with its health information content, applications and services. Cancer Connect has been recognized for producing award-winning, multi-media content which reaches over 1.5 million health information seekers in English, Japanese, and Spanish every month.

OMNI Health Media also produces and manages Women magazine, and The Web Chats with the Experts interactive series featuring thought leaders from institutions such as Memorial Sloan-Kettering, Johns Hopkins, Yale, and other prominent health centers.